Clinical trials
Active, not recruiting Renal Insufficiency, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
129 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 11 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 16 |
| 2023 | 11 |
| 2024 | 26 |
| 2025 | 21 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 129 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 10 |
| Universidade Federal Fluminense | 5 |
| AstraZeneca | 4 |
| Bayer | 4 |
| Boehringer Ingelheim | 4 |
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 2 |
| Renalytix AI, Inc. | 2 |
| University Health Network, Toronto | 2 |
| University Hospitals of Derby and Burton NHS Foundation Trust | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency, Chronic | 129 |
| Kidney Diseases | 17 |
| Kidney Failure, Chronic | 15 |
| Diabetes Mellitus, Type 2 | 12 |
| Hypertension | 12 |
| Diabetes Mellitus | 10 |
| Cardiovascular Diseases | 8 |
| Heart Failure | 8 |
| Renal Insufficiency | 8 |
| Inflammation | 7 |
Trials
Showing 1 to 25 of 129. Each trial links to its page on Pharma Observatory.
29 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.